Boston Professional Events List


Diabetes Summit (gtc)


Date
Apr 10, 2018 - 07:00 PM - Apr 11, 10:00 PM
Organizer
GTCbio - NewYorkEventsList
Location
Hyatt Regency Boston1 Avenue de LafayetteBoston, MA 02111United States,

Boston,
MA ,
US,
ZIP: 02111
Phone:


 

Description

GTCbio and the advisory board would like to invite you to the 11th Diabetes Summit to be held April 10-11, 2018 in Boston, MA. GTCbio’s Diabetes Summit encompasses the drug discovery and partnering aspects of diabetes in three tracks.. Experts from industry and academia will discuss strategies to target Type 1 and Type 2 diabetes in presentations, panels and round-table discussions that highlight basic research novel therapeutic targets, translation to the clinic, devices and digital aids, funding and partnering trends, emerging technologies and other relevant topics.

Joint Plenary Sessions:

  1. Opening Keynote Session – Historical Perspective & Current State of the Industry
  2. Round Table Discussions
  3. Ready, Set, Grow – New Company/Technology Pitch Competition & Lunch
  4. Award Ceremony & Closing Keynote Session – Predictions for future

Track 1: Diabetes Drug Discovery & Development Conference

  1. What’s New in Type I Diabetes – Targets, Models, Assays, etc.
  2. Translational and Clinical Development for Type I Diabetes
  3. What’s New in Type II Diabetes – Targets, Models, Assays, etc.
  4. Translational and Clinical Development for Type II Diabetes

Track 2: Diabetes Partnering & Deal-Making Conference

  1. Industry Partnering with Academia and CROs to Advance Research
  2. Investments from Private, Institutional and Public Sources

Track 3: Devices and Digital Aids in Diabetes Management Conference

  1. Next Generation Glucose Monitoring Devices and Technology
  2. The Role of “Being Digitally Connected” in Diabetes Management

 

 

Day 1 – Tuesday, April 10, 2018
Registration and Breakfast
Kick-off Keynote Session – Historical Perspective and State of the Industry
Morning Networking Break
Drug Discovery and Development for Type I Diabetes Diabetes Partnering and Deal-making
What’s New in Type I Diabetes – Targets, Models, Assays, etc. Industry Partnering with Academia and CROs to Advance Research
Sponsored Lunch Workshop
Translational and Clinical Development for Type I Diabetes Investments from Private, Institutional and Public Sources
Afternoon Networking Break
Round Table Discussions
Sponsored Reception and Poster Session
Dinner with Sponsors and 2018 AB (By Invitation Only)

 

Day 2 – Wednesday, April 11, 2018
Breakfast with Mentors from Academia and Industry
Drug Discovery and Development for Type II Diabetes Devices and Digital Aids in Diabetes Management
What’s New in Type II Diabetes – Targets, Models, Assays, etc. Next Generation Glucose Monitoring Devices and Technology
Morning Networking Break
Translational and Clinical Development for Type II Diabetes The Role of “Being Digitally Connected” in Diabetes Management
Ready, Set, Grow – New Company/Technology Pitch Competition & Lunch
Award Ceremony and Closing Keynote Session – Predictions for the Future
Conference Closes
2019 Advisory Board Meeting (By Invitation Only)



Speaker Details


PLENARY KEYNOTE SPEAKERS
Alan Cherrington
Alan Cherrington 
Professor of Molecular Physiology and Biophysics
Vanderbilt University

Alexander (Zan) Fleming
Alexander (Zan) Fleming 
President & Chief Exective Officer
Kinexum

Riccardo Perfetti
Riccardo Perfetti 
Head of Global Medical Team Diabetes, Vice President Global Medical Affairs, Sanofi
Sanofi Diabetes & Cardiovascular Business Unit

PLENARY SPEAKERS
John Campbell
John Campbell 
Associate Director, Research, Development & Innovation
SNBTS, National Science Laboratory

Douglas Losordo
Douglas Losordo 
Chief Medical Officer, Senior Vice President of Clinical, Medical & Regulatory Affairs
Caladrius Biosciences

Felicia Pagliuca
Felicia Pagliuca 
Vice President, Cell Biology R&D
Semma Therapeutics

Mark Zimmerman
Mark Zimmerman 
Vice President, Strategy and Business Development
ViaCyte

Diabetes Drug Discovery & Development 2017
DISTINGUISHED SPEAKERS
Raja-Elie Abdulnour
Raja-Elie Abdulnour 
Instructor of Medicine
Brigham and Women's Hospital

William W. Bachovchin
William Bachovchin 
Professor, Department of Biochemistry
Tufts University School of Medicine

Robin Barbour
Robin Barbour 
Senior Director Antibody and Assay Development 
Prothena Biosciences Inc.

Sudha B. Biddinger
Sudha Biddinger 
Associate Professor of Pediatrics
Children's Hospital of Boston

Bruno Doiron
Bruno Doiron 
Assistant Professor
University of Texas Health Science Center at San Antonio

Denise Faustman
Denise Faustman 
Director of the Immunobiology Laboratory at the Massachusetts General Hospital (MGH) 
Associate Professor of Medicine at Harvard Medical School

Judith Gorski
Judith Gorski 
Global Director, Scientific Engagement
Crown Bioscience Inc.

Jongsoon Lee
Jongsoon Lee 
Assistant Professor of Medicine
Joslin Diabetes Center, Harvard Medical School

Larry Steinman
Larry Steinman 
Professor, Pediatrics and Neurology
Stanford University

Pragalath Sundararajan
Pragalath Sundararajan 
Scientist
BERG Health

Diabetes Partnering & Deal-Making 2017
DISTINGUISHED SPEAKERS
Mostafa Analoui
Mostafa Analoui 
Executive Director
UCONN Ventures

Jonathan Behr
Jonathan Behr 
Managing Director
JDFR

Richard Berenson
Richard Berenson 
Chief Executive Officer
Thermalin Diabetes

Brian Bloomquist
Brian Bloomquist 
Senior Director, Global External Research and Development
Eli Lilly

Laura Brandner
Laura Brandner 
Manager of Global Software Innovation
Abbott

John Brooks III
John Brooks 
Managing Director 
Healthcare Capital LLC

MaryJulia Brosnan
MaryJulia Brosnan 
Director, External Collaborations and Scientific Alliances 
Pfizer

Victor Chapela
Victor Chapela 
Chief Executive Officer and Co-Founder
Suggestic

Benjamin Conway
Benjamin Conway 
Managing Director, Life Sciences
Consilium Partners

Shantanu Gaur
Shantanu Gaur 
Co-Founder & Chief Scientific Officer
Allurion Technologies

Robert Geho
Robert Geho 
Co-Founder and Chief Executive Officer 
Diasome Pharmaceuticals Inc

Karin Hehenberger
Karin Hehenberger 
Chief Executive Officer & Founder
LyfeBulb

Nathaniel	Kleintzman
Nathaniel Heintzman 
Director, Partner Portfolio
Dexcom

Scott Johnson
Scott Johnson 
Communications Lead
mySugr GmbH

Charles O'Connell
Charles O'Connell 
Founder and CEO
Fitscript

Nandan Padukone
Nandan Padukone 
Senior Vice President, Innovation 
Joslin Diabetes Center

Steven Russell
Steven Russell 
Assistant Professor of Medicine 
Massachusetts General Hospital

Aaron Schwartz
Aaron Schwartz 
Director, R&D Innovation Sourcing 
Novo Nordisk Inc.

Omid Veiseh
Omid Veiseh 
Founding Scientist and Head of Innovation 
Sigilon

 





Please contact the event manager Marilyn (marilyn.b.turner(at)nyeventslist.com ) below for: 
- Discounts for multiple participants.
- Require a price quotation.
- Require to pay by wire transfer or PayPal
- Invitation letter for visa applications

NO REFUNDS ALLOWED ON REGISTRATIONS 
-----------------------------------------------------------------
This Event is Brought to You by: 
GTCbio - NewYorkEventsList
http://www.NyEventsList.com
http://www.BostonEventsList.com
http://www.SFBayEventsList.com

MYL171011CEV CHA171109UPT

Event Categories
Keywords: fun, Clinical , conference , development , Fun , industry , institution, Management , network , networking




Comments








Events Calendar

SunMonTueWedThuFriSat
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30 1 2 3 4 5

Tag Cloud

Event Location

Newsletters

Subscribe
VIP Life Time Subscription to our Newsletters!
$399.99
$299.99